Lv11
20 积分 2021-03-15 加入
Amivantamab plus Lazertinib in Previously Untreated EGFR-Mutated Advanced NSCLC
2小时前
已完结
Panitumumab a novel drug in cancer treatment
21天前
已完结
MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling
1个月前
已完结
Integrative Omics Analysis Reveals Soluble Cadherin-3 as a Survival Predictor and an Early Monitoring Marker of EGFR Tyrosine Kinase Inhibitor Therapy in Lung Cancer
1个月前
已完结
Downregulated CDH3 is correlated with a better prognosis for LUAD and decreases proliferation and migration of lung cancer cells
1个月前
已完结
Antibody-drug conjugates for cancer therapy
3个月前
已完结
Expression profiles of HER2, EGFR, MET and FGFR2 in a large cohort of patients with gastric adenocarcinoma
3个月前
已完结
c-MET positivity and its relationship with histopathological findings in gastric carcinomas exhibiting HER2 gene expression
3个月前
已关闭
Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer
3个月前
已完结
Differential Expression of Epidermal Growth Factor Receptor, c-Met, and HER2/neu in Chordoma Compared With 17 Other Malignancies
4个月前
已完结
皖公网安备34019202002308
